David Elsbree Net Worth & Insider Trades
David Elsbree - Director, T2 Biosystems, Inc
What is David Elsbree's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Director, David Elsbree, is estimated to be about $29.45K . David Elsbree owns about 101,081 units of T2 Biosystems, Inc common stock. In the last 8 years at T2 Biosystems, Inc, David Elsbree has sold an estimated value of $11.35K worth.
What is David Elsbree's Past Insider Trading?
David Elsbree's largest purchase order was 6,250 units , worth over $102.94K on May 21, 2015. David Elsbree's largest sale order was 5,316 units , worth over $6.17K on January 7, 2020. In total, David Elsbree has made about 24 transactions over 8 years of their time at T2 Biosystems, Inc. David Elsbree usually trades in June, with the busiest year in 2015.
David Elsbree
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David Elsbree's' Mailing Address?
- Mailing address is C/o Acme Packet, Inc. 100 Crosby Drive Bedford MA 01730 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on April 11, 2022 by John Sperzel III who bought 30,000 units worth $15K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, Director, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||